Nanotechnology in Vaccines

Nanotechnology offers innovative approaches to enhance vaccine delivery, stability, and immune activation. Nanomaterials and nanocarriers, such as liposomes, polymeric nanoparticles, and virus-like particles, improve antigen presentation, targeted delivery, and controlled release. These technologies boost immunogenicity while reducing side effects and enabling lower-dose formulations. Research also explores combining nanotechnology with novel adjuvants and next-generation vaccine platforms to optimize efficacy. By integrating nanoscience with immunology, vaccines can become more precise, durable, and adaptable, providing advanced solutions for infectious diseases, cancer immunotherapy, and emerging global health challenges.

    Related Conference of Nanotechnology in Vaccines

    August 27-28, 2026

    22nd Global Biomarkers and Clinical Research Summit

    Paris, France
    September 14-15, 2026

    7th Global Summit on Digital Therapeutics

    Barcelona, Spain
    September 28-29, 2026

    13th International Conference on Stroke and Neurological Disorders

    Amsterdam, Netherlands
    October 19-20, 2026

    6th Euro-Global Summit on Probiotics & Nutraceuticals

    Paris, France
    November 16-17, 2026

    11th Global Summit on Midwifery and Womens Health

    Tokyo, Japan
    December 16-17, 2026

    7th Global Summit on Public Health

    Amsterdam, Netherlands
    January 18-19, 2027

    10th World Congress on PCOS and Reproductive Healthcare

    Bangkok, Thailand
    January 18-19, 2027

    44th International Conference on Women's Health

    Bangkok, Thailand
    February 01-02, 2027

    9th International Conference on Digital Health

    London, UK

    Nanotechnology in Vaccines Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in